R. Scott Greer - 09 Nov 2021 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-In-Fact
Issuer symbol
NKTR
Transactions as of
09 Nov 2021
Net transactions value
+$160,000
Form type
4
Filing time
09 Nov 2021, 16:05:30 UTC
Previous filing
24 Sep 2021
Next filing
20 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTR Common Stock Options Exercise $160,000 +12,500 +4.5% $12.80* 293,374 09 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Options Exercise $0 -12,500 -100% $0.000000* 0 09 Nov 2021 Common Stock 12,500 $12.80 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.